Side Effects Guide · Updated March 2026

GLP-1 Side Effects Month by Month: What to Actually Expect

The side effects are the thing nobody talks about honestly. Providers say "mild nausea." Reddit says "I couldn't eat for three days." The truth is somewhere in between, and it changes dramatically over time. Here is the real timeline based on clinical trial data and what I experienced on Mounjaro.

Disclosure: I am not a doctor. I write about GLP-1 medications based on my personal experience as a Mounjaro patient and my own research. Nothing on this site is medical advice. Always talk to your doctor before starting, stopping, or changing any medication. This site may earn commissions from providers linked on this page. Full disclaimer

The Headlines: How Common Are Side Effects?

Before the month-by-month breakdown, here are the overall rates from the major clinical trials:

Tirzepatide (Mounjaro/Zepbound) from SURMOUNT-1

Side EffectDrug (all doses)Placebo
Nausea24.6-31.0%9.5%
Diarrhea18.7-23.0%7.3%
Constipation11.7-17.1%5.8%
Vomiting8.3-12.2%1.7%
Discontinued due to side effects4.3-7.1%2.6%

Semaglutide (Ozempic/Wegovy) from STEP 1-3 (pooled)

Side EffectDrug (2.4mg)Placebo
Nausea43.9%16.1%
Diarrhea29.7%15.9%
Vomiting24.5%6.3%
Constipation24.2%11.1%
99.5% of GI events were non-serious

Two things jump out. First, semaglutide causes more GI side effects than tirzepatide across the board. The SURMOUNT-5 head-to-head trial confirmed this: 5.6% discontinued semaglutide due to GI issues versus only 2.7% for tirzepatide. Second, these numbers look scary, but 99.5% of GI events in the semaglutide trials were classified as non-serious. Most side effects are uncomfortable but not dangerous. For a full clinical comparison of both medications, see Mounjaro vs Ozempic.


Month 1: The Starting Dose

Typical dose: Semaglutide 0.25mg/week or tirzepatide 2.5mg/week

This is the adjustment period. Your body is meeting a GLP-1 receptor agonist for the first time, and it is figuring out what to do with the signals.

What most people feel:

What I experienced: The appetite suppression hit within 48 hours of my first Mounjaro injection. Nausea was there but manageable. The biggest surprise was how fast I felt full. A meal that used to be normal suddenly felt like Thanksgiving dinner. I learned quickly to eat smaller portions.

What the data says: Most side effects at the starting dose are mild. The low initial dose exists specifically to let your body adjust before ramping up. Only about 1-2% of participants in clinical trials discontinued at the starting dose level.

Tips for month 1:


Month 2-3: Dose Titration (This Is the Hardest Part)

Typical dose increases: Semaglutide 0.5mg then 1.0mg, or tirzepatide 5mg then 7.5mg

This is when side effects peak for most people. Each dose increase can trigger a new round of GI symptoms as your body adjusts to the higher level of GLP-1 activity.

What most people feel:

What I experienced: The jump from 2.5mg to 5mg of tirzepatide was noticeable. Nausea was stronger for 3 to 4 days after the dose increase. The sulfur burps showed up for the first time. I learned that eating high-fat meals the day of injection was a bad idea. By the end of the second week at 5mg, the symptoms faded.

What the data says: Most discontinuations happen during dose titration. The SURMOUNT-1 trial reported that 4.3% (5mg), 7.1% (10mg), and 6.2% (15mg) of tirzepatide participants discontinued due to adverse events. The highest dropout rates correlate with the steepest dose jumps.

Tips for months 2-3:


Month 4-6: Stabilization

Typical dose: Semaglutide 1.7-2.4mg or tirzepatide 10-15mg

If you have made it through titration, things get easier. Your body has adapted to the medication and most GI side effects either resolve or become manageable background noise.

What most people feel:

What I experienced: By month 4 on Mounjaro, the nausea was basically gone. Constipation was still there but manageable with fiber and hydration. The most noticeable thing was how quiet my brain was around food. The constant background chatter about what to eat next just stopped. That was the single biggest quality-of-life improvement.

What the data says: By the 4 to 6 month mark, most clinical trial participants had completed titration and were on maintenance doses. The rate of new adverse events drops significantly. The SURMOUNT-1 trial showed that most GI events occurred during the dose-escalation phase and resolved during the maintenance phase.


Month 6-12: Long-Term Maintenance

Typical dose: Maintenance at the dose that balances results with tolerability

What most people feel:

Muscle loss data: This is important. The STEP 1 trial found that lean mass accounted for 39-45% of total weight lost with semaglutide 2.4mg. The SURMOUNT-1 trial was slightly better for tirzepatide: lean mass was about 34% of total weight lost. Fat mass decreased 33.9% while lean mass decreased 10.9%.

What does this mean practically? If you lose 50 pounds, roughly 17-23 pounds of that could be muscle. This is why resistance training and adequate protein intake (0.7-1.0g per pound of body weight) are critical while on GLP-1 medication.

I track my own body composition with DEXA scans for exactly this reason. See our body composition tool to understand why tracking more than just weight matters.


Semaglutide vs. Tirzepatide: Which Has Fewer Side Effects?

The SURMOUNT-5 head-to-head trial (NEJM, May 2025) answered this directly:

MetricTirzepatideSemaglutide
Discontinued due to GI side effects2.7%5.6%
Weight loss achieved20.2%13.7%
Achieved 25%+ weight loss31.6%16.1%

Tirzepatide produced 47% more weight loss with roughly half the GI discontinuation rate. It is both more effective and better tolerated. This does not mean everyone will have fewer side effects on tirzepatide (individual responses vary), but the population-level data is clear.

For the full clinical comparison, see our Mounjaro vs Ozempic comparison.


When to Call Your Doctor

Most GLP-1 side effects are uncomfortable but not dangerous. However, there are red flags that require immediate medical attention:

These are rare. But knowing what to watch for matters.


What Actually Helps: Management Tips That Work

SymptomWhat HelpsWhat Does Not Help
NauseaEat smaller meals, ginger tea/chews, inject in evening, avoid fatty foodSkipping meals entirely (makes it worse)
ConstipationFiber supplement (psyllium husk), hydration (64+ oz/day), magnesium citrateRelying on laxatives long-term
Sulfur burpsAvoid carbonated drinks, eat slowly, avoid high-sulfur foods (eggs, broccoli)Antacids (different mechanism)
FatigueAdequate protein, stay hydrated, do not cut calories too aggressivelyCaffeine on empty stomach
Injection site reactionsRotate injection sites, let alcohol swab dry before injectingRubbing the site after injection
Food aversionsListen to your body, eat what sounds tolerable, do not force itTrying to eat your pre-medication portions

Compare GLP-1 providers and pricing

Browse All Providers →

The Bottom Line

GLP-1 side effects follow a predictable pattern: mild at the starting dose, worst during dose titration (months 2-3), and improving significantly by months 4-6. Nausea, diarrhea, constipation, and vomiting are the most common. Nearly all (99.5%) are non-serious. Tirzepatide causes fewer GI side effects than semaglutide based on head-to-head data.

The biggest long-term concern is muscle loss, not GI symptoms. Prioritize protein intake (0.7-1.0g per pound of body weight) and resistance training throughout treatment. Track your body composition, not just your weight.

If you are starting a GLP-1 program, check our provider directory to compare your options. For those on tirzepatide, our Mounjaro dosage guide covers what to expect at each dose level from 2.5mg to 15mg.


FAQ

How long do GLP-1 side effects last?

Most GI side effects (nausea, diarrhea, vomiting) peak during dose titration (months 2-3) and resolve or significantly improve by months 4-6. Constipation is the most persistent side effect and may continue throughout treatment. Each dose increase can temporarily bring back side effects for a few days to a week.

Is tirzepatide or semaglutide easier on the stomach?

Tirzepatide. The SURMOUNT-5 head-to-head trial showed a GI discontinuation rate of 2.7% for tirzepatide versus 5.6% for semaglutide. Tirzepatide also produced 47% more weight loss. It is both more effective and better tolerated at the population level, though individual responses vary.

How much muscle do you lose on GLP-1 medications?

Clinical trials show lean mass accounts for 34-45% of total weight lost. On tirzepatide (SURMOUNT-1), fat mass decreased 33.9% while lean mass decreased 10.9%. Resistance training and adequate protein intake (0.7-1.0g per pound of body weight) can help minimize muscle loss.

Can I slow down my dose titration?

Yes. Talk to your prescribing clinician. Many patients stay at a dose for an extra 2 to 4 weeks before increasing if side effects are bothersome. Slower titration typically means fewer side effects at each step. The standard titration schedule is a guideline, not a requirement.

Do GLP-1 side effects ever go away completely?

For most people, yes. By 4 to 6 months on a stable maintenance dose, GI side effects are either gone or minimal. Appetite suppression (a desired effect) typically persists. Constipation is the most likely side effect to remain ongoing, but it is manageable with fiber and hydration.


Guides:

Provider Reviews: Ro · Hims · MEDVi · Found · Calibrate

Compare: All Providers · Best GLP-1 Programs · All Guides

Compare GLP-1 Providers →